AIM ImmunoTech
33 hedge funds and large institutions have $5.6M invested in AIM ImmunoTech in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
3% more funds holding
Funds holding: 32 → 33 (+1)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
5% less capital invested
Capital invested by funds: $5.88M → $5.6M (-$282K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$387K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$335K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$222K |
| 4 |
VF
Virtu Financial
New York
|
+$149K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$40.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$157K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$151K |
| 3 |
BCM
Bayesian Capital Management
Brooklyn,
New York
|
-$91K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$36K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$29K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $18K | +$20K | +100 | New |
|
27
JP Morgan Chase
New York
| $5K | -$28.6K | -143 | -82% |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
|
SFS
29
Sowell Financial Services
North Little Rock,
Arkansas
| $1K | +$600 | +3 | New |
|
|
APA
30
American Portfolios Advisors
Holbrook,
New York
| $408 | – | – | – |
|
|
31
HighTower Advisors
Chicago,
Illinois
| – | -$151K | -701 | Closed |
|
|
BCM
32
Bayesian Capital Management
Brooklyn,
New York
| – | -$91K | -422 | Closed |
|
33
Millennium Management
New York
| – | -$38 | -177 | Closed |
|
|
34
Citadel Advisors
Miami,
Florida
| – | -$36K | -166 | Closed |
|
|
WS
35
Wedbush Securities
Los Angeles,
California
| – | -$29K | -133 | Closed |
|
|
ASN
36
Advisory Services Network
Atlanta,
Georgia
| – | -$3K | -13 | Closed |
|
|
IA
37
IFP Advisors
Tampa,
Florida
| – | +$200 | +1 | New |
|
AIM Hedge Fund Activity: Q4 2020 in Review
33 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q4 2020, worth a combined $5.6M — down 4.8% from $5.88M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new AIM positions and 6 closed out — a net gain of 1 holder — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $387K. The largest seller was GSA Capital Partners, cutting an estimated $157K.
- 33 institutional investors held AIM ImmunoTech (AIM) as of Q4 2020, up from 32 in Q3 2020.
- Funds reported $5.6M of AIM ImmunoTech stock for Q4 2020, down 4.8% quarter-over-quarter.
- 7 funds opened new AIM ImmunoTech positions in Q4 2020 and 6 closed out, a net change of +1 holder.
- The largest AIM ImmunoTech buyer in Q4 2020 was Morgan Stanley, an estimated $387K added.
- The largest AIM ImmunoTech seller in Q4 2020 was GSA Capital Partners, an estimated $157K sold.
Based on aggregated 13F filings for Q4 2020.